Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 32.65
-0.30 (-0.91%)
Sep 15, 2025, 5:35 PM CET
Dermapharm Holding SE Revenue
Dermapharm Holding SE had revenue of 275.48M EUR in the quarter ending June 30, 2025, a decrease of -2.93%. This brings the company's revenue in the last twelve months to 1.19B, up 3.86% year-over-year. In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B with 3.89% growth.
Revenue (ttm)
1.19B
Revenue Growth
+3.86%
P/S Ratio
1.49
Revenue / Employee
335.39K
Employees
3,610
Market Cap
1.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.20B | 44.72M | 3.89% |
| Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
| Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
| Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
| Dec 31, 2020 | 808.31M | 93.94M | 13.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 23.38B |
| Merck KGaA | 21.22B |
| Bayer Aktiengesellschaft | 46.17B |
| Fresenius SE & Co. KGaA | 22.28B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.47B |
| Fielmann Group AG | 2.40B |
| Carl Zeiss Meditec AG | 2.18B |
Dermapharm Holding SE News
- 20 days ago - Dermapharm's Steady Growth: H1 Stability & Q2 EBITDA Boost - Wallstreet:Online
- 20 days ago - EQS-News: Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter - Wallstreet:Online
- 4 weeks ago - EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 4 weeks ago - Dermapharm Holding SE: On Track for Growth in Q2 2025! - Wallstreet:Online
- 4 weeks ago - EQS-News: Dermapharm Holding SE remains on projected growth trajectory in Q2 2025 - Wallstreet:Online
- 2 months ago - EQS-DD: Dermapharm Holding SE: Wilhelm Beier, buy - Wallstreet:Online
- 2 months ago - EQS-DD: Dermapharm Holding SE: Dr. Andreas Eberhorn, buy - Wallstreet:Online
- 3 months ago - EQS-DD: Dermapharm Holding SE: Anja Schorn, buy - Wallstreet:Online